Table 5.
Risk of incident diabetes in patients with different follow-up period (1, 2, and 5 years) with the initial presence of one or both markers of preclinical cardiovascular disease
| P≤ | OR | CI 95.0% OR |
||||
|---|---|---|---|---|---|---|
| Lower | Upper | |||||
| No LVH (n = 3040) | LVH (n = 1136) | |||||
| Incident diabetes after 1 year follow-up | 8 (0.3%) | 7 (0.6%) | 0.14 | 1.00 | 1.00 | 1.01 |
| Incident diabetes after 2 years follow-up | 23 (0.8%) | 21 (1.8%) | 0.003 | 1.01 | 1.00 | 1.02 |
| Incident diabetes after 5 years follow-up | 106 (3.6%) | 74 (6.5%) | 0.0001 | 1.03 | 1.01 | 1.05 |
| No CA (n = 2628) | CA (n = 1548) | |||||
| Incident diabetes after 1 year follow-up | 6 (0.2%) | 9 (0.6%) | 0.104 | 1.00 | 1.00 | 1.01 |
| Incident diabetes after 2 years follow-up | 21 (0.8%) | 23 (1.5%) | 0.041 | 1.01 | 1.00 | 1.01 |
| Incident diabetes after 5 years follow-up | 92 (3.5%) | 88 (5.7%) | 0.001 | 1.02 | 1.01 | 1.04 |
| No LVH+CA (n = 3625) | LVH+CA (n = 551) | |||||
| Incident diabetes after 1 year follow-up | 10 (0.3%) | 5 (0.9%) | 0.038 | 1.01 | 1.00 | 1.01 |
| Incident diabetes after 2 years follow-up | 33 (0.9%) | 11 (2.0%) | 0.039 | 1.01 | 1.00 | 1.02 |
| Incident diabetes after 5 years follow-up | 144 (4.0%) | 36 (6.5%) | 0.009 | 1.03 | 1.00 | 1.05 |